WebApr 12, 2024 · The company has a market capitalization of $345.95 billion, a PE ratio of 52.76, a P/E/G ratio of 2.09 and a beta of 0.36. Eli Lilly and has a 1 year low of $276.83 and a 1 year high of $384.44. WebMar 25, 2024 · LLY PE Ratio (Forward) data by YCharts Note as well that the average forward price-to-earnings (P/E) ratio for the industry is 11.7, while for the S&P 500 it stands at 18.2. Eli Lilly's...
Eli Lilly (LLY) Pe Ratio (TTM) - Zacks.com
Web56 rows · The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Eli Lilly PE ratio as of March 31, 2024 is 43.25. Please refer to the Stock Price Adjustment Guide for more information on our … Pfizer (Pfe) - Eli Lilly PE Ratio 2010-2024 LLY MacroTrends Current and historical p/e ratio for Johnson & Johnson (JNJ) from 2010 to 2024. … The current P/S ratio for Eli Lilly as of February 01, 2024 is . For more … Eli Lilly annual/quarterly revenue history and growth rate from 2010 to 2024. … Historical daily share price chart and data for Eli Lilly since 1972 adjusted for splits. … AbbVie (Abbv) - Eli Lilly PE Ratio 2010-2024 LLY MacroTrends Novartis AG (Nvs) - Eli Lilly PE Ratio 2010-2024 LLY MacroTrends WebApr 12, 2024 · The stock’s fifty day moving average is $334.40 and its 200 day moving average is $346.30. Eli Lilly and Company has a fifty-two week low of $276.83 and a fifty-two week high of $384.44. The firm has a market capitalization of $345.95 billion, a PE ratio of 52.76, a PEG ratio of 2.09 and a beta of 0.36. e and o insurance for signing agents
LLY (Eli Lilly and Co) Shiller PE Ratio - GuruFocus
WebThe PEG ratio for this company is based on expected earnings for twelve months ending July 2024 Back to LLY Overview Data Provider: Data is provided by Zacks … WebEli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Ownership Insider Ownership Percentage Upgrade WebApr 6, 2024 · The p/e ratio for Eli Lilly and Co (LLY) stock today is 53.30. It's worsened by 7.79% from its 12-month average of 49.45. LLY's forward pe ratio is 39.06. The p/e ratio … csr basecoat 60